Mark Chen

Mr. Mark D.
Chen is an Independent Non-Executive Director at MEGAIN Holding (Cayman) Co. Ltd., an Independent Non-Executive Director at Global Cord Blood Corp.
and a Managing Partner at Pantheon Pacific Capital Management Ltd. He is on the Board of Directors at MEGAIN Holding (Cayman) Co. Ltd. and Global Cord Blood Corp.
Mr. Chen was previously employed as an Independent Director by Skystar Bio-Pharmaceutical Co., a Chairman, President & Chief Executive Officer by Pantheon China Acquisition Corp., a Managing Director by Ecc Advisors LLC, a Managing Director by Easton Capital Investment Group, and a Senior Executive Officer by Suredata, Inc. He also served on the board at Sonics, Inc. He received his undergraduate degree from Shanghai Jiao Tong University, a graduate degree from The Pennsylvania State University and an MBA from Columbia Business School.